Format

Send to

Choose Destination
Ann Epidemiol. 2014 Aug;24(8):625-7. doi: 10.1016/j.annepidem.2014.05.009. Epub 2014 May 22.

Systemic glucocorticoid use and early-onset basal cell carcinoma.

Author information

1
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
2
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT.
3
Yale Cancer Center, New Haven, CT; Departments of Dermatology and Surgery, Yale University School of Medicine, New Haven, CT.
4
Yale Cancer Center, New Haven, CT; Department of Genetics, Yale University School of Medicine, New Haven, CT.
5
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT. Electronic address: susan.mayne@yale.edu.

KEYWORDS:

Basal cell carcinoma; Case-control; Epidemiology; Glucocorticoids; Immunosuppressives; Keratinocyte carcinoma; Nonmelanoma skin cancer

PMID:
24958637
PMCID:
PMC4119504
DOI:
10.1016/j.annepidem.2014.05.009
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center